NDA 090291 describes CEFEPIME HYDROCHLORIDE, which is a drug marketed by
Acs Dobfar,
Astral,
Fosun Pharma,
Hospira Inc,
Qilu,
Sagent Pharms Inc, and
Samson Medcl, and is included in eight NDAs. It is available from
seven suppliers. Additional details are available on the
CEFEPIME HYDROCHLORIDE profile page.
The generic ingredient in CEFEPIME HYDROCHLORIDE is
cefepime hydrochloride. There are twenty
drug master file entries for this compound. Ten
suppliers are listed for this compound. Additional details are available on the
cefepime hydrochloride profile page.